Pfizer could make ‘tremendous investments’ in the US, but here’s why it’s choosing not to
Tuesday, 29 April 2025 () Pfizer Inc. (NYSE: PFE) chief executive Albert Bourla says uncertainty related to higher tariffs on pharmaceutical imports under the Trump administration is discouraging the company from investing in the US. Without the tariff uncertainty, the multinational could have made “tremendous investments” in research and development (R&D) as well as manufacturing in the US this year, […]
Tuesday, 29 April 2025 ()
Pfizer Inc. (NYSE: PFE) chief executive Albert Bourla says uncertainty related to higher tariffs on pharmaceutical imports under the Trump administration is discouraging the company from investing in the US. Without the tariff uncertainty, the multinational could have made “tremendous investments” in research and development (R&D) as well as manufacturing in the US this year, […]